View Agent
| Agent Info | |
| Agent: | Ruxolitinib |
| Synonyms: | Ruxolitinib phosphate;INC-424;INCB-018424;INCB-18424 |
| Drug Status For Certain Diseases: | Myelofibrosis(APPROVED) |
| Classification: | a potent JAK1/JAK2 inhibitor that has shown clinical benefit in patients with myelofibrosis |
| Target: | Tyrosine-protein kinase JAK2 |
| KEGG Pathway: | Herpes simplex infection PI3K-Akt signaling pathway Signaling pathways regulating pluripotency of stem cells Leishmaniasis Jak-STAT signaling pathway Adipocytokine signaling pathway Influenza A Toxoplasmosis Cholinergic synapse Tuberculosis Measles |
| Wiki Pathway: | Interferon gamma signaling Signaling by SCF-KIT EGF/EGFR Signaling Pathway TSH signaling pathway IL-4 Signaling Pathway Kit receptor signaling pathway Prolactin receptor signaling AGE/RAGE pathway Leptin signaling pathway Factors involved in megakaryocyte development and platelet production BDNF signaling pathway Interleukin-3, 5 and GM-CSF signaling Notch Signaling Pathway IL-6 signaling pathway Growth hormone receptor signaling Oncostatin M Signaling Pathway TSLP Signaling Pathway IL-5 Signaling Pathway Type II interferon signaling (IFNG) Interleukin-11 Signaling Pathway IL17 signaling pathway Mesodermal Commitment Pathway Interleukin-2 signaling JAK/STAT EPO Receptor Signaling IL-3 Signaling Pathway Serotonin Receptor 2 and STAT3 Signaling |